Come up with a name for your new list and we'll add to it:
Ikaria raised a round of funding on December 24, 2013. Investors include
Madison Dearborn Partners.
Ikaria is a critical care company focused on developing and commercializing therapies designed to address the significant needs of critically ill patients. The company's product, INOMAX (Inhaled Nitri…